365
Views
15
CrossRef citations to date
0
Altmetric
Original Article

People who inject drugs remain hard-to-reach population across all HIV continuum stages in Central, Eastern and South Eastern Europe – data from Euro-guidelines in Central and Eastern Europe Network

ORCID Icon, , , , , , , , , & show all
Pages 277-286 | Received 25 Jul 2018, Accepted 11 Dec 2018, Published online: 21 Feb 2019

References

  • Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013;8:e81355.
  • May MT, Gompels M, Delpech V, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014;28:1193–1202.
  • Trickey A, May MT, Vehreschild JJ, et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4:e349–e356.
  • Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316:171–181.
  • Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375:830–839.
  • UNAIDS. 90–90–90. An ambitious treatment target to help end the AIDS Epidemic; 2014. Available from: http://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf.
  • WHO, Consolidated guidelines on the use of antiretroviral drugs for preventing and treating HIV infection, Recommendations for Public Health Approach, Second Edition, 2016. Available from: http://apps.who.int/iris/bitstream/10665/208825/1/9789241549684_eng.pdf?ua=1.
  • Kowalska JD, Wójcik G, Rutkowski J, et al. Modelling the cost-effectiveness of HIV care shows a clear benefit when transmission risk is considered in the calculations – a message for Central and Eastern Europe. PLoS One. 2017;12:e0186131.
  • European Centre for Disease Prevention and Control. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2014 progress report. Stockholm: ECDC; 2015. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/dublin-declaration-continuum-of-care-2014.pdf
  • Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res Ther. 2016;13:35.
  • Beyrer C, Crago AL, Bekker LG, et al. An action agenda for HIV and sex workers. Lancet. 2015;385:287–301.
  • Beyrer C, Sullivan PS, Sanchez J, et al. A call to action for comprehensive HIV services for men who have sex with men. Lancet. 2012;380:424–438.
  • Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010;376:355–366.
  • Altman D, Aggleton P, Williams M, et al. Men who have sex with men: stigma and discrimination. Lancet. 2012;380:439–445.
  • Decker MR, Crago AL, Chu SK, et al. Human rights violations against sex workers: burden and effect on HIV. Lancet. 2015;385:186–199.
  • Jurgens R, Csete J, Amon JJ, et al. People who use drugs, HIV, and human rights. Lancet. 2010;7;376:475–485.
  • Harper GW, Fernandez IM, Bruce D, et al. The role of multiple identities in adherence to medical appointments among gay/bisexual male adolescents living with HIV. AIDS Behav. 2013;17:213–223.
  • Semugoma P, Beyrer C, Baral S. Assessing the effects of anti-homosexuality legislation in Uganda on HIV prevention, treatment, and care services. Sahara J. 2012;9:173–176.
  • Tucker JD, Ren X. Sex worker incarceration in the People's Republic of China. Sex Transm Infect. 2008;84:34–35. Discussion 6.
  • Kerr T, Hayashi K, Ti L, et al. The impact of compulsory drug detention exposure on the avoidance of healthcare among injection drug users in Thailand. Int J Drug Policy. 2014;25:171–174.
  • Palepu A, Tyndall MW, Chan K, et al. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther. 2004;9:713–719.
  • Meyer JP, Althoff AL, Altice FL. Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis. 2013;57:1309–1317.
  • World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations; 2014 [cited 2015 May 24]. Available at: http://apps.who.int/iris/bitstream/10665/128048/1/9789241507431_eng.pdf?ua=1&ua=1.
  • Grinsztejn B, Hosseinipour MC, Ribaudo HJ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014;14:281–290.
  • Tanser F, Bärnighausen T, Grapsa E, et al. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339:966–971.
  • Raymond A, Hill A, Pozniak A. Large disparities in HIV treatment cascades between eight European and high-income countries – analysis of break points. J Int AIDS Soc. 2014;17:19507.
  • Gourlay A, Noori T, Pharris A, et al. The HIV continuum of care in European Union countries in 2013: data and challenges. Clin Infect Dis. 2017;64:1644–1656.
  • Brown AE, Attawell K, Hales D, et al. Monitoring the HIV continuum of care in key populations across Europe and Central Asia. HIV Med. 2018;19:431–439.
  • Kholoud PE, Gourlay A, Attawell K, et al. Substantial heterogeneity in progress toward reaching the 90-90-90 HIV target in the WHO European Region. J Acquir Immune Defic Syndr. 2018;79:28–31.
  • Kowalska JD, Oprea C, de Witt S, et al. Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration – a comprehensive meeting report. HIV Med. 2017;18:370–375.
  • Jain MK, Maulsby C, Kinsky S, et al. 2015–2020 National HIV/AIDS Strategy Goals for HIV linkage and retention in care: recommendations from program implementers. Am J Public Health. 2016;106:399–401.
  • Drew RS, Rice B, Rüütel K, et al. 11W continuum of care in Europe and Central Asia. HIV Med. 2017;18:490–499.
  • European Centre for Disease Prevention and Control. Thematic report: Continuum of HIV care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. Available at: https://ecdc.europa.eu/sites/portal/files/documents/Continuum-of-HIV-care-2017.pdf.
  • Koirala S, Deuba K, Nampaisan O, et al. Facilitators and barriers for retention in HIV care between testing and treatment in Asia—a study in Bangladesh, Indonesia, Lao, Nepal, Pakistan, Philippines and Vietnam. PLoS One. 2017;12:e0176914.
  • Tomori C, Kennedy CE, Brahmbhatt H, et al. Barriers and facilitators of retention in HIV care and treatment services in Iringa, Tanzania: the importance of socioeconomic and sociocultural factors. AIDS Care Psychol Socio-Med Aspects AIDS/HIV. 2014;7:26.
  • Yehia BR, Stewart L, Momplaisir F, et al. Barriers and facilitators to patient retention in HIV care. BMC Infect Dis. 2015;15:246.
  • Mocroft A, Lundgren J, Antinori A, et al. Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro Surveill. 2015;20:7–18.
  • Nyika H, Mugurungi O, Shambira G, et al. Factors associated with late presentation for HIV/AIDS care in Harare City, Zimbabwe, 2015. BMC Public Health. 2016;16:369.
  • Hachfeld A, Ledergerber B, Darling K, et al. Reasons for late presentation to HIV care in Switzerland. J Int AIDS Soc. 2015;18:20317.
  • Hughes AJ, Christine LM, Scheer S, et al. Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States. J Acquir Immune Defic Syndr. 2014;66:80–89.
  • Stephen M, Blanchard JF, Kang H, et al. AIDS in South Asia, Understanding and Responding to a Heterogeneous Epidemics.” The World Bank, Washington DC, 2006, p. 113.
  • Cassels S, Camlin CS. Geographical mobility and heterogeneity of the HIV epidemic. Lancet HIV. 2016;3:e339–e341.
  • Palk L, Blower S. Geographic variations in sexual behavior can explain geospatial heterogeneity in the severity of the HIV epidemic in Malawi. BMC Med. 2018;16:1–9. doi:10.1186/s12916-018-1006-x.
  • Kathryn R, Mayer K, Beyrer C. The HIV treatment cascade in men who have sex with men, people who inject drugs and sex workers. Curr Opin HIV AIDS. 2015;10:420–429.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.